![]() |
Technical Data |
|
C2444-01 |
CD99 (MIC2, p30/32MIC2, Ewing’s Sarcoma Marker, E2 Antigen) |
|
|
Description: CD99 antigen is expressed on most hematological cells, especially at high density on thymocytes, T cells and the cells of T-cell leukemias and lymphomas and is differentially expressed on early hematopoietic stages, but lacking on fetal B cells and some B cell lines, eosinophils, granulocytes and NK-cell line YT. CD99 antigen may be involved in T-cell adhesion processes and may have a role in hematopoietic adhesion pathways. Applications: Suitable for use in Immunofluorescence, Flow Cytometry, and Immunohistochemistry. Other applications have not been tested. Recomended Dilution: Immunofluorescence: 0.125ug/10e6 cells or 100ul peripheral blood. Flow Cytometry: 0.125ug/10e6 cells or 100ul peripheral blood Immunohistochemistry: Acetone-fixed frozen and formalin-fixed paraffin. Immunohistochemistry: frozen (acetone-fixed) and paraffin sections. Optimal dilutions to be determined by researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
|
|||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||